PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.75%
Revenue growth under 50% of 2127.T's 9.62%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
1.77%
Gross profit growth under 50% of 2127.T's 14.63%. Michael Burry would be concerned about a severe competitive disadvantage.
4.04%
EBIT growth below 50% of 2127.T's 24.50%. Michael Burry would suspect deeper competitive or cost structure issues.
15.41%
Operating income growth similar to 2127.T's 16.90%. Walter Schloss would assume both share comparable operational structures.
13.61%
Net income growth under 50% of 2127.T's 29.72%. Michael Burry would suspect the firm is falling well behind a key competitor.
13.59%
EPS growth under 50% of 2127.T's 29.75%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
13.59%
Diluted EPS growth under 50% of 2127.T's 29.75%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.02%
Slight or no buybacks while 2127.T is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.02%
Slight or no buyback while 2127.T is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while 2127.T is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.00%
Negative FCF growth while 2127.T is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
160.73%
10Y revenue/share CAGR at 50-75% of 2127.T's 242.55%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
56.92%
5Y revenue/share CAGR 1.25-1.5x 2127.T's 42.51%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
34.46%
3Y revenue/share CAGR 1.25-1.5x 2127.T's 26.59%. Bruce Berkowitz might see better product or regional expansions than the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
138.65%
Net income/share CAGR at 50-75% of 2127.T's 198.06%. Martin Whitman might question if the firm’s product or cost base lags behind.
37.21%
5Y net income/share CAGR similar to 2127.T's 36.20%. Walter Schloss might see both on parallel mid-term trajectories.
-32.24%
Negative 3Y CAGR while 2127.T is 21.01%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
331.44%
10Y equity/share CAGR in line with 2127.T's 366.57%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
86.25%
5Y equity/share CAGR is in line with 2127.T's 81.73%. Walter Schloss would see parallel mid-term profitability and retention policies.
35.83%
3Y equity/share CAGR above 1.5x 2127.T's 10.68%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
166.67%
Dividend/share CAGR of 166.67% while 2127.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
No Data
No Data available this quarter, please select a different quarter.
9.04%
Our AR growth while 2127.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.29%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.36%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.52%
BV/share growth above 1.5x 2127.T's 0.15%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.02%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-0.62%
We cut SG&A while 2127.T invests at 9.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.